In this regard, the administration of IAP to mice fed a high-fat diet prevents endotoxemia and the associated metabolic syndrome [8], while Akp3 (duodenal AP) knock-out mice show faster weight gain [9], visceral fat accumulation and hepatic steatosis, as well as insulin resistance. Here, INS is linked to fatty liver disease.